A detailed history of Black Rock Inc. transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,473,973 shares of CLPT stock, worth $7.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,473,973
Previous 1,470,056 0.27%
Holding current value
$7.94 Million
Previous $9.98 Million 0.42%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$6.03 - $7.86 $23,619 - $30,787
3,917 Added 0.27%
1,473,973 $10 Million
Q4 2023

Feb 13, 2024

BUY
$4.46 - $7.07 $471,966 - $748,161
105,822 Added 7.76%
1,470,056 $9.98 Million
Q3 2023

Nov 13, 2023

SELL
$5.01 - $7.09 $47,805 - $67,652
-9,542 Reduced 0.69%
1,364,234 $6.83 Million
Q2 2023

Aug 11, 2023

BUY
$6.54 - $10.58 $6.3 Million - $10.2 Million
962,892 Added 234.35%
1,373,776 $9.95 Million
Q1 2023

May 12, 2023

SELL
$7.33 - $10.63 $13,619 - $19,750
-1,858 Reduced 0.45%
410,884 $3.47 Million
Q4 2022

Feb 13, 2023

SELL
$7.7 - $11.21 $600 - $874
-78 Reduced 0.02%
412,742 $3.5 Million
Q3 2022

Nov 14, 2022

BUY
$9.82 - $16.49 $1.13 Million - $1.9 Million
115,127 Added 38.67%
412,820 $4.28 Million
Q2 2022

Aug 12, 2022

SELL
$7.09 - $13.65 $6.18 Million - $11.9 Million
-872,160 Reduced 74.55%
297,693 $3.88 Million
Q1 2022

May 12, 2022

SELL
$7.8 - $11.6 $50,715 - $75,423
-6,502 Reduced 0.55%
1,169,853 $12.2 Million
Q4 2021

Feb 10, 2022

BUY
$11.08 - $18.86 $141,635 - $241,087
12,783 Added 1.1%
1,176,355 $13.2 Million
Q3 2021

Nov 09, 2021

BUY
$16.58 - $22.25 $238,121 - $319,554
14,362 Added 1.25%
1,163,572 $20.7 Million
Q2 2021

Aug 11, 2021

BUY
$17.23 - $22.77 $19.8 Million - $26.2 Million
1,149,210 New
1,149,210 $21.9 Million

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $132M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.